OncoCyte Price to Sales Ratio 2014-2025 | OCX
Historical PS ratio values for OncoCyte (OCX) over the last 10 years. The current P/S ratio for OncoCyte as of May 22, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| OncoCyte P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-05-22 | 3.44 | 16.12 | |
| 2025-03-31 | 3.06 | $0.21 | 14.34 |
| 2024-12-31 | 2.38 | $0.15 | 15.71 |
| 2024-09-30 | 2.85 | $0.08 | 36.17 |
| 2024-06-30 | 2.95 | $0.12 | 24.11 |
| 2024-03-31 | 2.93 | $0.17 | 17.08 |
| 2023-12-31 | 2.50 | $0.20 | 12.50 |
| 2023-09-30 | 3.12 | $0.21 | 14.97 |
| 2023-06-30 | 4.60 | $0.17 | 27.41 |
| 2023-03-31 | 7.09 | $0.15 | 46.48 |
| 2022-12-31 | 6.42 | $0.19 | 34.68 |
| 2022-09-30 | 14.60 | $-0.30 | 0.00 |
| 2022-06-30 | 17.99 | $-0.10 | 0.00 |
| 2022-03-31 | 29.80 | $0.31 | 95.04 |
| 2021-12-31 | 43.40 | $0.50 | 85.96 |
| 2021-09-30 | 71.20 | $1.09 | 65.05 |
| 2021-06-30 | 114.80 | $1.04 | 109.91 |
| 2021-03-31 | 103.80 | $0.64 | 163.32 |
| 2020-12-31 | 47.80 | $0.37 | 130.23 |
| 2020-09-30 | 27.80 | $0.21 | 130.08 |
| 2020-06-30 | 38.20 | $0.05 | 785.21 |
| 2020-03-31 | 49.00 | $0.01 | 0.00 |
| 2019-12-31 | 45.00 | 0 | 0.00 |
| 2019-09-30 | 42.00 | 0 | 0.00 |
| 2019-06-30 | 49.80 | 0 | 0.00 |
| 2019-03-31 | 79.00 | 0 | 0.00 |
| 2018-12-31 | 27.60 | 0 | 0.00 |
| 2018-09-30 | 50.00 | 0 | 0.00 |
| 2018-06-30 | 51.00 | 0 | 0.00 |
| 2018-03-31 | 42.00 | 0 | 0.00 |
| 2017-12-31 | 93.00 | 0 | 0.00 |
| 2017-09-30 | 151.00 | 0 | 0.00 |
| 2017-06-30 | 104.00 | 0 | 0.00 |
| 2017-03-31 | 119.00 | 0 | 0.00 |
| 2016-12-31 | 141.00 | 0 | 0.00 |
| 2016-09-30 | 100.80 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.098B | $0.002B |
| OncoCyte Corporation is primarily focused on the development of novel, non-invasive blood and urine diagnostic tests for detection of cancer. OncoCyte Corporation is based in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.174B | 25.17 |
| Elevance Health (ELV) | United States | $86.874B | 11.21 |
| CVS Health (CVS) | United States | $76.179B | 9.47 |
| Cencora (COR) | United States | $56.230B | 19.56 |
| DiDi Global (DIDIY) | China | $23.297B | 35.36 |
| Natera (NTRA) | United States | $20.821B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.571B | 13.31 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.522B | 0.00 |
| CochLear (CHEOY) | Australia | $11.391B | 0.00 |
| Revvity (RVTY) | United States | $10.665B | 18.35 |
| ICON (ICLR) | Ireland | $10.255B | 9.53 |
| Viatris (VTRS) | United States | $9.976B | 3.43 |
| Doximity (DOCS) | United States | $9.570B | 44.57 |
| Avantor (AVTR) | United States | $8.763B | 12.73 |
| HealthEquity (HQY) | United States | $8.657B | 42.59 |
| Medpace Holdings (MEDP) | United States | $8.422B | 22.37 |
| Sonic Healthcare (SKHHY) | Australia | $8.157B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.660B | 13.05 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $3.994B | 36.97 |
| Bausch + Lomb (BLCO) | Canada | $3.976B | 23.44 |
| Sotera Health (SHC) | United States | $3.480B | 19.77 |
| Surgery Partners (SGRY) | United States | $2.896B | 37.67 |
| Alignment Healthcare (ALHC) | United States | $2.867B | 0.00 |
| Concentras Parent (CON) | United States | $2.744B | 15.86 |
| Organon (OGN) | United States | $2.259B | 2.40 |
| Ardent Health Partners (ARDT) | United States | $2.117B | 9.02 |
| GeneDx Holdings (WGS) | United States | $1.921B | 73.99 |
| Premier (PINC) | United States | $1.910B | 14.50 |
| Progyny (PGNY) | United States | $1.791B | 39.42 |
| PACS (PACS) | United States | $1.494B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.364B | 27.29 |
| Teladoc Health (TDOC) | United States | $1.211B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.200B | 9.13 |
| Establishment Labs Holdings (ESTA) | $1.066B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.953B | 14.88 |
| Agilon Health (AGL) | United States | $0.911B | 0.00 |
| Nutex Health (NUTX) | United States | $0.901B | 13.61 |
| AMN Healthcare Services Inc (AMN) | United States | $0.830B | 7.77 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.614B | 4.14 |
| InnovAge Holding (INNV) | United States | $0.543B | 0.00 |
| LifeMD (LFMD) | United States | $0.523B | 0.00 |
| Enhabit (EHAB) | United States | $0.520B | 42.75 |
| Auna S.A (AUNA) | Luxembourg | $0.505B | 11.37 |
| Sonida Senior Living (SNDA) | United States | $0.465B | 0.00 |
| SBC Medicals (SBC) | United States | $0.398B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.388B | 0.00 |
| Oncology Institute (TOI) | United States | $0.226B | 0.00 |
| Beauty Health (SKIN) | United States | $0.217B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.214B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.137B | 22.33 |
| So-Young (SY) | China | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.071B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.052B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.022B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |